Payer formulary tier increases of apixaban: how patients respond and potential implications
{{output}}
Objective: To assess potential impacts of formulary tier increases of apixaban-an efficacious oral anticoagulant (OAC) for preventing stroke in patients with atrial fibrillation (AF)-on patients' prescription drug plan (PDP) swit... ...
